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Abstracts / Pediatric Hematology Oncology Journal 1 (2016) S1eS33 S3the commonest causes of fever with thrombocytopenia in our institute. In
a majority of cases, thrombocytopenia was transient and asymptomatic,
with only one case requiring platelet transfusion.
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TO STUDY THE FACTORS AFFECTING QUALITY OF LIFE IN CHILDREN
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Background: Hemophilia is the most common severe bleeding disorder in
the world caused due to a single gene mutation. India has the second
largest number of Hemophilia patients in the world. Being a chronic dis-
ease, hemophilia has signiﬁcant impact on the quality of life which needs
to be assessed. This study was designed to assess the qol in children with
hemophilia and identify the factors that predict their qol, in order to better
plan and distribute the health care resources.
Material and Methods: This was a cross-sectional case control study
which included 30 children suffering from Hemophilia as cases and 30
normal healthy siblings' as controls aged between 5-12 years. The quality
of life assessment was performed using the Pediatric Quality of Life In-
ventory (PedsQoL) 4.0 Generic Core Scale. Two separate questionnaires
were administered for children between age group of 5 to 7 years and 8 to
12 years. For the purpose of analysis Joint, Muscle and Intracranial bleeds
were together classiﬁed as Major bleeds, whereas skin and mucosal bleeds
as Minor bleeds. Data was analyzed using Stata Version 13. The means
between two groups were compared using the unpaired and paired t-test
(for different groups, and pre-and post-means respectively and Analysis of
Variance (ANOVA) for comparison of means across more than two groups.
The proportions were compared using the chi square test or the Fisher's
exact test (for low expected cell counts).
Results: The mean age of the study group was 8.08 years, while that of the
control group was 8.88 years. Eighty percent had Hemophilia A and 20%
had Hemophilia B. Severe hemophilia was seen in 87% and 13% had
moderate Hemophilia. The mean scores of the child self-report and parent
proxy report (results of the questionnaire answered by the parent) of the
study group was 79.81 and 72.75 respectively, which was signiﬁcantly
lower as compared to the control group, suggestive of impaired quality of
life .The mean scores of the parent proxy report were signiﬁcantly lower
than the child report scores for both the study and control groups, indi-
cating parents reporting of impaired quality of life of the affected children.
Joint bleeds were present in 36.66%, 73.3% had muscle bleeds and 16.66%
had intracranial bleeds. Target joints were present in 13.33%. The median
number of hospitalizations was 3 from date of diagnosis till the inclusion of
the patients in the study group. The quality of life was signiﬁcantly affected
in children with more number of bleeding episodes and with the presence
of target joints. The qol was not signiﬁcantly affected by the age of diag-
nosis, duration of illness and the socioeconomic status.
Conclusion: The Quality of Life of childrenwith Hemophilia is signiﬁcantly
impaired as compared to the general population. Number of Hospitaliza-
tions, presence of target joints, number of bleeding episodes, age at
diagnosis and duration of disease were associated with the quality of life of
children with hemophilia and hence rehabilitation measures should be
encouraged along with primary factor prophylaxis and encouraging the
patients to learn home treatment to improve scores and quality of life.
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QUALITY OF LIFE OF PARENTS OF CHILDREN SUFFERING FROM
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Background: Haematological and oncological disorders are accorded a
low public health priority in India, although they form a large groupcollectively and have signiﬁcant mortality and morbidity, accounting for
immense suffering of patients and their family members. Prior research
has emphasized on identifying these parental psychosocial risk factors in
order to improve care and to reduce treatment abandonment, thus deliver
the beneﬁt of vastly improved therapeutic strategies in this ﬁeld. This
study aimed to evaluate the impact of chronic benign haematological
disorders and paediatric malignancies on overall quality of life (QOL) and
psychological status of parents in a low income setting and to correlate it
with well-matched controls and socioeconomic status.
Methodology: We conducted a comparative cross sectional study. 94
parents of children diagnosed with benign haematological disorders and
malignancies were enrolled in study group and 50 well matched parents of
healthy children as control group .World Health Organization (WHO) QOL-
Bref questionnaire was used for the assessment of the QOL in four do-
mains, physical health (D1), psychological health (D2), social relationships
(D3), and environment (D4) with 24 questions. This questionnaire has
been translated and validated in over 40 countries. Depression Anxiety
Stress Scale is a self-report instrument that quantitatively measures
distress along the axes of three subscales: depression, anxiety and stress.
The socioeconomic status was classiﬁed by Kuppuswamy scale which is a
composite score of education, occupation and monthly income.
Results: Of 94 patients in study group, 58.5% (55) were males and 41.4%
(39) were females aged 0-17 years. Of 50 patients in control group, 58%
(29) were males and 42% (21) were females. The study group had 29.7%
(28) cases of benign hematological disorders, 47.8% (45) hematological
malignancies, and 22.3% (21) solid tumors. Mean score of QOL for study
group in domains D1, D2, D3 and D4 was 50.28, 44.39, 51.09 and 42.74
whereas that of control group was 79.38, 76.32, 80.58 and 72.86 respec-
tively. The difference was statistically signiﬁcant (p<0.001) in all domains.
Mean depression, anxiety and stress score of the study group was 22.79,
19.77 and 22.96, whereas that of the control group was 7.1, 8.06 and 8.54
respectively and this too was statistically signiﬁcant. 81.9% (77) belonged
to the lower whereas 18.08% (17) belonged to the upper socioeconomic
class in the study group. There was no statistical signiﬁcance between the
socioeconomic status of the study and the control group. The correlation
between socioeconomic status and QOL was statistically insigniﬁcant in all
domains except in D2 and hence QOL mostly reﬂects impact of the disease
rather than the socioeconomic status.
Conclusion: Study group had diminished scores in all domains of QOL and
were signiﬁcantly more depressed, anxious and stressed. Poorer quality of
life of study group was mostly due to impact of the disease rather than
socioeconomic status. This study emphasizes the need to design effective
interventions to aid these families and ultimately help in improving the
outcome of these children.
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Introduction: Reavan in 1988 noted that several risk factors for cardio-
vascular diseases commonly cluster together, and he recognised them as a
disease, named syndrome X, currently known as metabolic syndrome.
Metabolic syndrome is a group of disorders related to insulin resistance,
characterized clinically by central obesity, hyperglycemia, dyslipidemia
and hypertension. There is a growing body of evidence indicating that
pediatric cancer survivors are at a greater risk of developing metabolic
syndrome. We studied the prevalence of metabolic syndrome in children
with cancer who completed their treatment and on follow up.
Methodology: All relevant past medical data (of the disease, treatment
and all events) were collected from the medical records. Tanner staging
was performred, Height was measured using a Harpenden stadiometer.
Weight/WAIST circumference were measured. The body mass index
(BMI) was calculated as weight (kg)/(height (m)2). BMI 90th centile as
per CDC chart was taken as abnormal. Blood pressure was measured on
the right arm of the patient. Presence of family history of diabetes, car-
diovascular diseases and hypercholesterolemiawere taken. Fasting Blood
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tional diabetes federation) criteria to assess the metabolic syndrome
among cancer survivors. This study was approved by our university
ethics comittee.
Results: Seventy ﬁve children who fulﬁlled the inclusion criteria were
included in this study, out of which 48 were males and 27 were females.
Among these, majority of children are treated for acute lymphoblastic
leukemia. 8.25% of total population satisﬁed the criteria of metabolic
syndrome. Age, gender, diagnosis, modality of treatment were not to be of
statistical signiﬁcance, however majority of children with metabolic syn-
drome are in adolescent group.
Conclusion: With the better care committed to childrenwith cancer even in
developing country, the survival rates are greatly improving and so meta-
bolic syndrome is becoming the major target for intervention in the follow
up of cancer survivors. As metabolic syndrome cannot treated by a single
drug therapy, it is necessary to have cancer survivors follow up screening.
Keywords: Metabolic syndrome, cancer survivors, children.
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FORGOTTEN MEMBER OF THE FAMILY?; SIBLINGS OF CHILDREN WITH
CANCER e THE PSYCHOSOCIAL IMPACT OF THE DIAGNOSIS IN THE
SIBLINGS!
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Introduction: Siblings of the family are exposed to signiﬁcant stress when
a child is diagnosed with cancer. Concern about the ill child, disruptions in
family roles/ routines, decreased contact with family members, and addi-
tional demands for caregiving/other responsibilities in the home are
common after a cancer diagnosis in the family household. In some cases,
siblings are also called upon to serve as a donor for stem cell transplant,
which can introduce other ethical and psychosocial concerns. These unique
challenges leave siblings of children with cancer at risk for acute and long-
term psychosocial difﬁculties. However, there are no current evidence-
based standards for the supportive care of siblings of childrenwith cancer.
Methodology: The Objectives of the study was to assess the psychosocial
impact of childhood cancer on siblings.
The study was conducted in two survivor camps at Sri Ramachandra
Medical College and Research Institute, a tertiary centre for paediatric
haemato-oncology. An interviewer administered questionnaire was
applied, which was framed after thorough literature review along with
clinical psychologists contributions and validated by national and inter-
national paediatric oncologists. Parents and siblings were interviewed
after obtaining appropriate consent. The questionnaire focuses on 5
essential domains: Medical, Well-Being, Emotional, Scholastic, and Social
performance (family time). Other domains like social withdrawal, food
habits and behavioural changes were analysed.
Results: 44 siblings of cancer children were included in this study. Sig-
niﬁcant experiences of negative emotional reactions (lonely, depressed,
sadness, unwanted, anger, and guilt) were expressed. Out of which, the
majority of 48% were depressed and 26% were found to be angry. Academic
performance of 58% were affected. The poor quality of life in the categories
of emotional, family, and social domains showed a signiﬁcant rise of per-
centage, coming up to 96.7% of compromised leisure activities.
Family-level themes such as loss of attention was signiﬁcant in 77% of the
group that was studied. Positive outcomes including increased sibling
maturity, empathy and learning to take responsibilities was observed by
the family in 88.9% of the study group. 18% were oriented towards showing
interest in participating for social cause in the future.
Conclusions:
 Research regarding siblings of children with cancer continues to be
methodologically limited particularly in a developing country such asIndia.
 Siblings of children with cancer are psychosocially at-risk group and
should be provided with appropriate supportive services.
 Early identiﬁcation of behavioral changes is mandatory.
 Appropriate interventions should be developed.
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Nishant Verma, Archana Kumar, Vishal Pooniya. King George's Medical
University, Lucknow, UP, India
E-mail address: drnishantaiims@gmail.com (N. Verma).
Background/Objective: Outcome of childhood cancer in Low Middle in-
come countries (LMIC) like India continues to be poor as compared to
High-income countries. One of the proposed reasons for this poor outcome
is delay in diagnosis and treatment. There are only few studies from LMICs
which look into the magnitude of delays and reasons behind them.
Methods: A prospective observational study was conducted in the Pedi-
atric Oncology Unit at KGMU, Lucknow, UP from 01/01/2015 to 30/06/2015.
All the newly diagnosed childhood cancer patients were included in this
study. Parents of these children were interviewed and data regarding the
date of onset of symptoms, date of ﬁrst contact with a health care pro-
fessional, date of ﬁrst visit to a pediatric oncology center, date of diagnosis
and date of treatment initiation were recorded onto a standard proforma.
Figure 1 describes the deﬁnition of various types of delays used for this
study. Demographic and clinical details were recorded from hospital
medical records.
Results: Parents of 111 children with newly diagnosed childhood cancer
were interviewed. Median total delay for the entire cohort was 58 days
(IQR 33-97). The most important contributor to this total delay was delay
in referral (median-40d; IQR 17-80d). Patient delay (median-5d), Diag-
nostic delay (median-4d) and Treatment delay (median-2d), were signif-
icantly lower than Referral delay. While girls had a higher total delay
(median-67d) as compared to boys (median-50d) (P¼0.046), place of
residence of family (Rural vs Urban), family income (below poverty line vs
above poverty line) and education status of the parents did not affect the
delay. Total delay was least in children with Wilms tumor (median-27d)
and acute leukemia (median-42d) and maximum in Hodgkins lymphoma
(median-285d). All the children had consulted at least one medical pro-
fessional (median-3, range 1-20) before coming to oncology center. 21% of
parents gave a history of using alternative form of medicine. Using alter-
native treatment was associated with longer total delay (median 69d vs
49d; P¼0.012). Parents of 10 children (9%) believed that cancer is incurable
and this belief was instigated in them either by relatives (7) or doctors (3).
Common causes of delay, which were identiﬁed were inadequate referral
(in 76% children) and ﬁnancial constraints for the family (in 35% children).
After the ﬁnal diagnosis of cancer was established, 14% children (15/111)
abandoned before any treatment could be established. 14 of these families
could be tracked using phone calls. The reasons, which they cited for
abandonment included ﬁnancial burden of treatment (9/14), too many
investigations (9/14) and belief that cancer is incurable (6/14).
Conclusions: Referral delay was recognized as the biggest hindrance for
timely management of childhood cancer in our region. There is a need to
train health care providers at primary, secondary and tertiary levels to help
early recognition of cancer symptoms and prompt referral to appropriate
pediatric oncology centers. Steps should also be taken to prevent inap-
propriate use of alternative forms of treatment for childhood cancer as it
interferes with timely diagnosis and referral.
Figure 1. Diagrammatic representation of various types of delays in the management
of childhood cancer.
